Friday Pop Quiz 2/14/2025
A 40-year-old female develops a wing of extra tissue in all of her fingernails which developed gradually through the years. You mention it is due to scarring in the nail matrix. What is the most common dermatologic association with this condition?
A. Lichen planus
B. Trauma
C. Stevens-Johnson syndrome
D. Alopecia areata
E. Renal failure
To find out the correct answer and read t …
A 40-year-old female develops a wing of extra tissue in all of her fingernails which developed gradually through the years. You mention it is due to scarring in the nail matrix. What is the most common dermatologic association with this condition?
A. Lichen planus
B. Trauma
C. Stevens-Johnson syndrome
D. Alopecia areata
E. Renal failure
To find out the correct answer and read t … 
Histopathology can be rendered useless without good clinical information, according to Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sokumbi about traps to avoid in challenging clinicopathologic scenarios. Learn how not to miss a diagnosis of dermatomyosit … 
Bimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.
Bimekizuma … 
Ruxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT … 
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …